Kenya has been chosen as one of nine countries for the early rollout of Lenacapavir, an injectable drug for HIV prevention, approved by the World Health Organization (WHO).

• Lenacapavir will be available in Kenya by January 2026.
• The announcement was made at the 13th International AIDS Society Conference in Kigali, Rwanda.
• Dr. Tedros Adhanom Ghebreyesus, WHO Director General, emphasized its potential as a game-changer for high-risk individuals.